Cite
Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
MLA
Traianos, Emmanuella Young, et al. “Serum CXCL13 Levels Are Associated with Lymphoma Risk and Lymphoma Occurrence in Primary Sjögren’s Syndrome.” Rheumatology International, vol. 40, no. 4, Apr. 2020, pp. 541–48. EBSCOhost, https://doi.org/10.1007/s00296-020-04524-5.
APA
Traianos, E. Y., Locke, J., Lendrem, D., Bowman, S., Hargreaves, B., Macrae, V., Tarn, J. R., & Ng, W.-F. (2020). Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren’s syndrome. Rheumatology International, 40(4), 541–548. https://doi.org/10.1007/s00296-020-04524-5
Chicago
Traianos, Emmanuella Young, James Locke, Dennis Lendrem, Simon Bowman, Ben Hargreaves, Victoria Macrae, Jessica Rachael Tarn, and Wan-Fai Ng. 2020. “Serum CXCL13 Levels Are Associated with Lymphoma Risk and Lymphoma Occurrence in Primary Sjögren’s Syndrome.” Rheumatology International 40 (4): 541–48. doi:10.1007/s00296-020-04524-5.